CliffBio
small molecule

NULYTELY

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAzurity Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameNULYTELY
Active ingredientPOLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
Strength420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT
Dosage formFOR SOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalApril 1991
Marketing statusRX

More from Azurity Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.